Finance

Lists
BCCOY:OTCMKTS
BICO Group 4 ADR Representing Ord Shs
0,71 US$
0,00%
(0,00) 1D
14 ოქტ, 12:14:14 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BCCOY...
Mkt. cap
1,68 მლრდ.
Avg. vol.
20,00
Volume
0,00
52-wk high
0,75 US$
52-wk low
0,35 US$
Beta
1,95
Shares outstanding
276,30 მლნ.
No. of employees
554
Mkt. cap
1,68 მლრდ.
Avg. vol.
20,00
Volume
0,00
52-wk high
0,75 US$
52-wk low
0,35 US$
Beta
1,95
Shares outstanding
276,30 მლნ.
No. of employees
554
News stories
From web sources and news partners
Profile
Bico Group is a Swedish bioconvergence company that designs and supplies technologies and services to enhance biology research. It focuses on commercializing technologies for life science research as well as bioprinting. Bico Group began by producing bio-inks and bioprinters for culturing different cell types to enable applications like patient-derived implants. Bico Group was the first company to provide a standardized bio-ink product for sale over the internet. The company has ongoing collaborations with organizations including AstraZeneca, MedImmune, MIT and Takara Bio, and its bioprinters are used for research at Harvard University, Merck, Novartis, the U.S. Army, Toyota, Johnson & Johnson and more. Wikipedia
About BICO Group 4 ADR Representing Ord Shs
CEO-
Employees554
Founded27 იან. 2016
Headquarters-
SectorHealth care
Websitebico.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
386,90 მლნ.
451,30 მლნ.
329,90 მლნ.
336,10 მლნ.
Cost of goods sold
174,20 მლნ.
215,90 მლნ.
151,30 მლნ.
136,90 მლნ.
Cost of revenue
174,20 მლნ.
215,90 მლნ.
151,30 მლნ.
136,90 მლნ.
Research and development expenses
50,10 მლნ.
48,80 მლნ.
49,30 მლნ.
56,90 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
204,10 მლნ.
204,30 მლნ.
224,80 მლნ.
179,70 მლნ.
Operating expense
259,60 მლნ.
249,50 მლნ.
269,80 მლნ.
229,40 მლნ.
Total operating expenses
433,80 მლნ.
465,40 მლნ.
421,10 მლნ.
366,30 მლნ.
Operating income
-46,90 მლნ.
-14,10 მლნ.
-91,20 მლნ.
-30,20 მლნ.
Other non operating income
-
-8,40 მლნ.
-
-100,00 ათ.
EBT including unusual items
-1,11 მლრდ.
-57,00 მლნ.
-127,50 მლნ.
-34,90 მლნ.
EBT excluding unusual items
-73,30 მლნ.
-73,30 მლნ.
-105,30 მლნ.
-23,60 მლნ.
Income tax expense
-2,20 მლნ.
2,20 მლნ.
3,80 მლნ.
2,30 მლნ.
Effective tax rate
0,20%
-3,86%
-2,98%
-6,59%
Other operating expenses
5,40 მლნ.
-3,60 მლნ.
-4,30 მლნ.
-7,20 მლნ.
Net income
-612,70 მლნ.
-55,00 მლნ.
-131,30 მლნ.
-37,20 მლნ.
Net profit margin
-158,36%
-12,19%
-39,80%
-11,07%
Earnings per share
-
-
-
-
Interest and investment income
2,70 მლნ.
212,00 მლნ.
9,10 მლნ.
20,30 მლნ.
Interest expense
-29,10 მლნ.
-11,90 მლნ.
-23,20 მლნ.
-13,60 მლნ.
Net interest expenses
-26,40 მლნ.
200,10 მლნ.
-14,10 მლნ.
6,70 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,04 მლრდ.
48,40 მლნ.
-20,10 მლნ.
27,00 მლნ.
Gain or loss from assets sale
-
-480,30 მლნ.
-
-
AI content may include mistakes. Learn more
Google აპები